The page is the record's research on the issuer — no analyst, no rating, no view. # Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Ginkgo Bioworks Holdings, Inc., listed on NYSE under ticker DNA, ISIN US37611X2099. The LEI is not on the record. Security type is Corporate, sector 2836 Biological Products, (No Diagnostic Substances), jurisdiction United States, Delaware. Segment is not on the record. Status is listed, not halted. ## The disclosure read The record holds 80 filings in the twelve months to 2026-11-08, across 52 filing days. The median gap between filing days is 5 days, against an NYSE median of 6.0 days and a sector median of 5.5 days. Days from the latest filing to the record date are 3, against an NYSE median of 4.0 days and a sector median of 4.0 days. The latest filing is dated 2026-11-05 and is of type results. The issuer's filings by type are 39 regulatory filings, 26 directors' dealings, 7 results, 3 corporate news, 3 AGM/EGM, 1 director change and 1 takeover. The NYSE median filing count is 64.0 and the sector median is 65.5. ## Auditor The auditor of record is Deloitte & Touche LLP, located in Boston, Massachusetts. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. Domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001830214.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NYSE/DNA (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1830214/000162828026012346/dna-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NYSE/DNA (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NYSE/DNA · public-record only · the same page signed and receipted: get_research at https://mcp.getissuer.ai/mcp